TD SYNNEX (NYSE:SNX), a leading global distributor and solutions aggregator for the IT ecosystem, has received a score of 100 on the Human Rights Campaign (HRC) Foundation’s 2026 Corporate Equality ...

Police say officers responded to the crash in the 400 block of South Jefferson Street around 2:15 a.m. Sunday and found a white sedan on fire after it had crashed into a highway support column. The ...

The stock market turmoil unleashed by the artificial-intelligence industry reflects two fears that are increasingly at odds. One is that AI is poised to disrupt entire segments of the economy so ...

Inflation cooled for a third straight month in January as the headline figure for the Consumer Price Index came in at 2.4% year-over-year. Core CPI was at 2.5% year-over-year, down from 2.6% in ...

TIOBE Index for February 2026: Specialized Languages Gain Ground as Python’s Lead Eases Your email has been sent Python remains comfortably ahead in February, but the composition of the top 10 is ...

Mattel struggles with reliance on toys and inventory issues Hasbro's digital gaming success boosts investor confidence Mattel plans $110 million digital investment in 2026, pressuring margins The ...

Python still holds the top ranking in the monthly Tiobe index of programming language popularity, leading by more than 10 percentage points over second-place C. But Python’s popularity actually has ...

Get any of our free daily email newsletters — news headlines, opinion, e-edition, obituaries and more. In Montana we have a congressional delegation that boasts of two Navy SEALs. For years we have ...

Can we please request a day or two of not covering Donald Trump and his useless ramblings, toxic takeaways, lies, exaggerations, willfully misleading comments? It only becomes a race to the bottom for ...

The Jan. 2 editorial about Chicago-region transit and workers’ return to the Loop (“More workers are coming downtown in the new year. It’s showtime for our transit systems”) rightly highlights the ...

The steady stream of FDA untitled letters that began in September is showing no signs of letting up in the new year. The regulator’s Office of Prescription Drug Promotion (OPDP) has already sent out ...